Transcription regulatory networks governing the genesis, maturation and maintenance of vertebrate brain serotonin (5-HT) neurons determine the level of serotonergic gene expression and signaling throughout an animal's lifespan. Recent studies suggest that alterations in these networks can cause behavioral and physiological pathogenesis in mice. Here, we synthesize findings from vertebrate loss-of-function and gain-of-function studies to build a new model of the transcriptional regulatory networks that specify 5-HT neurons during fetal life, integrate them into CNS circuitry in early postnatal life and maintain them in adulthood. We then describe findings from animal and human genetic studies that support possible alterations in the activity of serotonergic regulatory networks in the etiology of mental illness. We conclude with a discussion of the potential utility of our model, as an experimentally well-defined molecular pathway, to predict and interpret the biological effect of genetic variation that may be discovered in the orthologous human network. 
r e v i e w "It is possible that the 5-HT in our brains plays an essential part in keeping us sane …" -Sir John Gaddum, 1954 Ever since the heady days of Sir John Gaddum's animal and selfadministration studies of the serotonergic hallucinogen lysergic acid diethylamide, there has been an incessant quest for an understanding of brain 5-HT function and its importance in behavior and neuropsychiatric disease. An extensive literature that began to appear soon after Gaddum's and others' groundbreaking studies of 5-HT (refs. 1,2) has implicated altered 5-HT signaling in the etiology of an apparently disparate group of neurodevelopmental disorders, including depression, anxiety, obsessive compulsive disorder, disorders of energy balance, autism, schizophrenia and sudden infant death syndrome 3 . The wide range of disorders linked to serotonergic dysfunction is not surprising, as the 5-HT transmitter system innervates nearly all of the cytoarchitectonic regions of the brain and spinal cord and has been implicated in the modulation of seemingly every human behavior and physiological process orchestrated by the nervous system. But what is quite striking, in view of this impressive breadth of influence, is that the 5-HT system originates from an exceedingly small proportion of neurons that are genetically programmed to produce and use 5-HT as a neurotransmitter. The number of 5-HT neurons in the mouse brain is estimated to be 26,000 (ref. 4) and, in the human brain, roughly 300,000 (refs. 5,6) . The prevailing hypothesis of the role of 5-HT neurons in mental health disorders is that genetic determinants and their interaction with environmental factors program too little or too much 5-HT signaling emanating from these small numbers of neurons at critical developmental stages, which consequently disrupts the developmental trajectories of CNS circuit formation and thereby results in susceptibility to mental illness 7 . As the genetic determinants of early 5-HT system function, the regulatory programs that implement serotonergic neurogenesis, and determine the level of brain 5-HT signaling, have gained considerable attention over the past decade for their potential biological relevance to neuropsychiatric disorders [8] [9] [10] [11] .
Here, we review recent progress in understanding the regulatory programs governing 5-HT neuron development and function. From recent loss-of-function and gain-of-function findings, we assemble a model of the transcriptional network comprising the 5-HT regulatory programs that direct the generation, maturation and maintenance of brain 5-HT neurons. We then discuss the potential utility of the network as an experimentally well-defined molecular pathway in understanding the elusive mechanisms of 5-HT-related neuropsychiatric disease pathogenesis.
5-HT neuron identity
The small numbers of 5-HT neurons in the brain express hundreds of genes that encode generic molecular and cellular characteristics shared by all types of neurons, such as the ion channels necessary for action potential generation and the proteins required for the release of neurotransmitter at synapses. However, it is the selection for expression of a serotonergic-type gene battery comprising tryptophan hydroxylase 2 (Tph2), aromatic amino acid decarboxylase (Aadc, also known as Ddc), serotonin transporter (Slc6a4, also known as Sert), vesicular monoamine transporter (Slc18a2, also known as Vmat2), monoamine oxidase A and B (Maoa and Maob), 5-HT1a autoreceptor (Htr1a), 5-HT1b autoreceptor (Htr1b), and the genes encoding the synthetic and recycling enzymes for tetrahydrobiopterin cofactor (BH 4 ) synthesis, that endows these cells with the specialized capacity to synthesize, transport, autosense, inactivate through reuptake and metabolize 5-HT, thus establishing its physiological function as a neurotransmitter (Fig. 1) . Although each of these genes is essential for serotonergic function, none of them uniquely define brain serotonergic neuron identity, as all of them, even the rate-limiting 5-HT synthetic enzyme Tph2, are expressed in other neural and non-neural 12 cell types. Thus, what determines serotonergic neuron identity is the integration of 5 2 0 VOLUME 15 | NUMBER 4 | APRIL 2012 nature neuroscience r e v i e w aggregate serotonergic characteristics encoded by the serotonergictype gene battery with generic neuronal characteristics 8 .
The set of genetic instructions that coordinates the expression of serotonergic and neuronal characteristics constitutes an intrinsic regulatory program that directs serotonergic neuron identity in the brain 13 . Cell-fate regulatory programs comprise complex networks of interacting transcription factors, associated signaling proteins and the cis regulatory sequences through which combinations of transcription factors control target genes 14 . A particular regulatory program specifies and then progressively transforms proliferating neural progenitors into neurons of a particular identity, such as those able to synthesize 5-HT. The regulatory program controlling serotonergic neurogenesis, however, is not sufficient to equip 5-HT neurons with the capacity to exert widespread neuromodulatory influence on CNS circuitry. Thus, additional intrinsic programs likely regulate 5-HT neuron maturation when these neurons are physiologically connected with 5-HT receptor bearing postsynaptic circuitry in widely distributed serotonergic axonal termination zones. Recent studies have also found that intrinsic serotonergic regulatory programs act in adulthood to maintain serotonergic signaling and plasticity.
Rhombencephalic 5-HT neuron development
The neuroanatomical development and distribution of vertebrate 5-HT neurons has been extensively studied in rats, primates and zebrafish with immunohistochemical approaches [15] [16] [17] [18] [19] , and more recently in mice with genetic-based fate mapping 20 (Fig. 2) . 5-HT neuron development comprises neurogenesis and maturation. During the relatively brief period of neurogenesis, embryonic days 9.5-12 (E9.5-12), mouse 5-HT neurons are specified and born in the ventral rhombencephalon (Fig. 2a) . These newly born 5-HT neurons ultimately cluster in several disparate regions of the midbrain, pons and medulla to form the raphe nuclei (Fig. 2b) .
The period of 5-HT neuron generation, as with that of all neurons, comprises several experimentally recognizable stages (Fig. 2c) . During the first stage, the secreted signaling molecules sonic hedgehog and fibroblast growth factors 4 and 8 regionally pattern the mid-hindbrain neuroepithelium along the dorsoventral and anterior-posterior axes, respectively, to specify serotonergic progenitors in the ventral hindbrain [7] [8] [9] . The first progenitors committed to a serotonergic fate appear in rhombomere 1 (r1), where they generate 5-HT neurons from about E9.5 to E10.5. 5-HT neurons are born about a day later in r2 and r3, as progenitors at these longitudinal levels initially generate visceromotor neurons (vMN) before becoming competent to generate 5-HT neurons 21 . A similar motorneuron to 5-HT neuron switch in progenitor fate occurs with similar temporal characteristics in r5-r8, such that caudal 5-HT neurons are born virtually simultaneously with those in the rostral domain. However, there is a 1-2-d delay in the synthesis of 5-HT in these newly born caudal cells 22 . The switch to serotonergic neurogenesis is never launched under normal circumstances in r4, and motor neurogenesis persists in this rhombomere 21 .
During the next stage, progenitors exit the cell cycle to become postmitotic neuronal precursors that do not yet possess serotonergic identity. Serotonergic identity is then acquired through coordinate expression of serotonergic-type gene battery. The newborn 5-HT neurons are phenotypically immature (Fig. 2c) and have not yet been integrated into neural circuitry. Thus, beginning immediately after the birth of the 5-HT neurons and extending to at least the end of the third postnatal week, mouse 5-HT neurons undergo a series of complex maturation events 16, 22 . These events include cell body migration, dendritic growth, expression of 5-HT autoregulatory pathways, formation of highly collateralized axonal pathways and synaptogenesis.
Intrinsic serotonergic transcription regulatory network
Loss-of-function and gain-of-function studies in mouse and chick have greatly illuminated the idiosyncratic intrinsic roles of eight transcriptional regulators and their complex interactions that progressively restrict the fate of progenitors to a 5-HT phenotype. The proneural bHLH factor Ascl1 (also known as Mash1) and the homeodomain protein Nkx2.2 are expressed at the vMN and 5-HT progenitor stages at all rhombomeric levels of the hindbrain, and their induction is likely an early response to sonic hedgehog signaling [23] [24] [25] . Their expression is extinguished as progenitors exit the cell cycle to become postmitotic precursors. The forkhead box factor Foxa2 is expressed at a very low level in vMN progenitors, but is induced as these progenitors switch to serotonergic neurogenesis 26 . It is not expressed in r4, where 5-HT neurons are not generated. Next, expression of the zinc finger proteins Gata2, Gata3 and Insm1 is initiated as serotonergic progenitors transit to the postmitotic precursor stage 25, 27, 28 . . Aadc, aromatic l-amino acid decarboxylase; Sert, serotonin transporter; Vmat2, vesicular monoamine transporter 2; Maoa, monoamine oxidase; Gfrp, GTP cyclohydrolase I feedback regulator; Gch1, GTP cyclohydrolase 1; Ptps, 6-pyruvoyl-tetrahydropterin synthase; Spr, sepiapterin reductase; Pcbd, pterin-4-alpha-carbinolamine dehydratase; Qdpr, quinoid dihydropteridine reductase. BH 4 Specification of serotonergic progenitors Nkx2.2. Loss of Nkx2.2 does not affect 5-HT neurons in r1, but 5-HT neuron production is substantially reduced, although not eliminated, in all of the posterior rhombomeres 20, 23 . The role, if any, of Nkx2.2 in r1 is not clear and it might be compensated by the coexpressed paralog Nkx2.9. However, analysis of Nkx2.2 and Nkx2.9 compound mutants has not been reported. Nkx2.2 regulates 5-HT neuron production in rhombomeres posterior to r1 by controlling a temporal switch (Fig. 3 ) in progenitor fate from vMN to 5-HT neurons 21 . It does so by regulating the timing of expression of another homeodomain protein, Phox2b, which functions as a proneural factor in vMN generation, except in r1, where 5-HT, but not vMN, neurons are generated. In Phox2b mutants, vMN genesis fails throughout the hindbrain 32 and 5-HT neurons are instead prematurely generated in r2, r3 and r5-r8, and ectopic neurons are generated in r4 (ref. 21 ). In addition to being essential in the vMN to 5-HT temporal switch, Nkx2.2 is also required to switch on the downstream transcriptional network that directly induces the serotonergic-type gene battery (Fig. 4) . In Foxa2. Foxa proteins are well known for having multiple roles in single-cell lineages 33 and the serotonergic lineage is no exception. Foxa2 acts in a temporally regulated manner to establish serotonergic progenitor domains in the ventral hindbrain and to activate expression of transcription factors that are directly involved in 5-HT neuron precursor differentiation 26 . Foxa2 represses the homeodomain protein Phox2b in r1 ( Fig. 3) and permanently suppresses the vMN fate while the promoting serotonergic fate in resident progenitors. In more posterior rhombomeres, except for r4, Phox2b initially represses Foxa2, thereby directing a motor neuron fate of resident progenitors up to about E10.5 ( Fig. 3) . After E10.5, a reciprocal repression occurs in which Foxa2 represses Phox2b to switch progenitors to a serotonergic fate. In r4, Phox2b permanently represses Foxa2, thereby preventing serotonergic neurogenesis (Fig. 3) . The mechanism underlying the Figure 3 Serotonergic progenitor specification. In r1, Foxa2 continually represses Phox2b expression to block production of visceral motor neuron (vMN) progenitors and promotes the production of 5-HT progenitors. In r2-3 and r5-r8, Nkx2.2 initially induces Phox2b, which in turn represses Foxa2. This subcircuit establishes a motoneuron fate of ventral progenitors in r2-r3 and r5-r8. These progenitors produce motor neurons from E9.5~10. cross repressive switch is not understood. Ongoing Foxa2 function is required in the same progenitors for activation of Gata2, Lmx1b and Pet-1 (Fig. 4) 26 . The loss of Foxa2 at this later stage results in ~50% loss of 5-HT neurons in the hindbrain.
Ascl1. Despite being expressed in motor neuron progenitors during vMN genesis, loss of Ascl1 does not appear to cause defects in motor neuron number or phenotype 34 . Ascl1 function emerges only after Phox2b is shut off in motor neuron progenitors and Ascl1 has been shown to have multiple functions at this stage 24 . First, Ascl1 performs a proneural function to regulate serotonergic neurogenesis, as the expression of all markers (Gata2, Gata3, Pet-1, Lmx1b and 5-HT) of newly generated serotonergic postmitotic precursors is nearly abolished throughout the hindbrain in Ascl1 −/− mutants. Second, Ascl1 is required, together with Nkx2.2 and Foxa2, for induction of the inferred (see below) parallel Gata2-and Gata3-dependent serotonergic neuron differentiation networks 24 (Fig. 4) . Third, Ascl1 directly activates the expression of the zinc finger protein Insm1 as mitotically active serotonergic progenitors are exiting the cell cycle 27 . Chromatin immunoprecipitation (ChIP) studies have revealed a direct interaction of Ascl1 with a conserved binding site located 4.5 kb upstream of the Insm1 transcription start site (Fig. 4) . Moreover, Insm1 expression is greatly reduced or eliminated in Ascl1 mutant serotonergic precursors throughout the ventral hindbrain 27 .
Insm1. Direct regulation of Insm1 by Ascl1 suggests that Insm1 is critical for the acquisition of the serotonergic phenotype. In general, loss-of-function studies confirmed this prediction, but also revealed some unexpected nuances in downstream effects that illuminate unique characteristics of Insm1 function 27 . First, widely varying deficiencies of 5-HT-positive neurons were detected in Insm1 mutants along the anterior-posterior axis of the hindbrain, with levels in r2 and r3 being severely affected. Second, although Insm1 loss of function did not change progenitor specification, Lmx1b expression was uniformly and severely reduced. However, deficits in Gata2 and Pet-1 expression were variable along the anterior-posterior axis. Third, initial Aadc expression was not affected in Insm1 mutants, but Tph2 expression was greatly reduced along the entire anterior-posterior axis. By E16.5, however, Aadc expression was reduced, consistent with the deficit in Pet-1 expression at this stage. These finding suggest a complex network role for Insm1 in which it perhaps directly regulates Tph2 expression while reinforcing Ascl11-, Foxa2-and Nkx2.2-directed Gata2 expression in a feedforward manner (Fig. 4) . Alternatively, because Insm1 is critical for Lmx1b expression 27 and loss of Lmx1b results in the virtually complete loss of 5-HT and Tph2 expression 31, 35 , perhaps Insm1 indirectly regulates Tph2 through direct regulation of Lmx1b expression (Fig. 4) .
Gata2
. Studies of Gata2's involvement in 5-HT development are complicated because all Gata2 −/− embryos die between E9.5 and E11.5 from severe hematopoietic defects 36 . However, it was found that induction of Pet-1 at E10.5 fails to occur in the rostral hindbrain of Gata2 −/− embryos 25 . Furthermore, in contrast with wild-type or Gata2 +/− explants, no 5-HT is detected in ventral neural tube explants taken from E8 Gata2 −/− embryos and analyzed after 5 d in culture 25 . At all longitudinal levels, Gata2 is absolutely required for induction of Pet-1 (and presumably Lmx1b), but not Gata3 (ref. 25) . Thus, it can be inferred that Nkx2.2, Ascl1 and Foxa2 induce a Gata3-dependent network and a parallel Gata2-dependent network, the latter of which in turn induces Lmx1b and Pet-1 expression (Fig. 4) . Several lines of evidence suggest that Gata2 directly induces Pet-1 expression at the postmitotic precursor stage. First, as described above, Pet-1 expression is completely eliminated in explants of Gata2 mutant neural tubes 25 . Second, ChIP studies have shown that Gata2 occupies highly conserved Gata binding sites in the upstream Pet-1 enhancer region. Third, point mutation of these sites greatly diminishes expression of a Pet-1 enhancer-regulated transgene reporter in mouse brain 5-HT neurons 37 .
Differentiation of postmitotic precursors
Coordinate induction of the serotonergic genes encoding 5-HT synthesis, reuptake, vesicular transport and metabolism is the final step r e v i e w in serotonergic neurogenesis. Lmx1b, Pet-1 and Gata3 are induced in postmitotic precursors just before initiation of 5-HT synthesis and all are necessary for induction of the serotonergic-type gene battery. None of these factors are dependent on each other for their induction; thus, they provide parallel transcriptional inputs to induce serotonergic gene expression (Fig. 4) . In addition, the loss of these factors does not affect progenitors. However, expression of all three of these factors is maintained across the lifespan, which suggests that they may be terminal selectors 38 that have distinct functions at different stages of life. Indeed, recent findings have shown this to be true for Pet-1 and Lmx1b.
Lmx1b. Lmx1b has numerous critical roles in CNS development, including development of the isthmic organizer that induces the midhindbrain boundary, mesencephalic dopaminergic neurons and spinal dorsal horn neurons 39 . In homozygous Lmx1b mutants, 5-HT neuron precursors are generated in normal numbers, but virtually all of them fail to activate expression of Tph2, Sert, Vmat2 and 5-HT synthesis 31, 35 . Despite being induced normally in Lmx1b mutants, Pet-1 expression begins to decline at E12.5 and expression is no longer detectable by E14.5 (ref. 31 and 35) . Thus, Lmx1b is needed to maintain Pet-1 expression at later stages of embryogenesis (Fig. 4) . Lmx1b and Pet-1 share many targets, and Lmx1b's regulation of Pet-1 suggests that these factors operate in a feedforward manner to regulate serotonergic genes. Neonatal death precluded postnatal analyses of constitutively targeted homozygous Lmx1b mutant mice. However, survival was improved when Lmx1b was conditionally targeted in 5-HT neurons, which allowed serotonergic Lmx1b deficiency to be studied in the postnatal period. Analyses of these targeted mice showed that, although mutant 5-HT neuron cell bodies were present in the fetal hindbrain, nearly all of them were missing postnatally 40 . These findings confirmed that Lmx1b has a cell autonomous function in 5-HT neurons and demonstrated that it is uniquely required, among the known network factors, for postnatal survival of these cells. The SIM1 transcription factor may also be required for the maintenance or survival of a small subset of 5-HT neurons in the dorsal raphe nucleus (DRN) 41 .
Although genetic programs appear to specify 5-HT neuron progenitors independent of activity-responsive signaling pathways, recent studies in the embryonic Xenopus hindbrain have found that a portion of 5-HT neuron precursors are dependent on calcium spike activity for serotonergic differentiation 42 . Overexpression of sodium channels or potassium channels that increased or decreased calcium spike activity led to almost 30% increases or decreases in the numbers of Lmx1b-positive and Tph-positive neurons, respectively. Lmx1b was identified as a node for the activity-dependent regulation of 5-HT neuron number, as these alterations were prevented when Lmx1b expression was suppressed. The alterations in 5-HT neuron numbers and Lmx1b expression also led to changes in the swimming behavior of Xenopus larvae 42 . Together, these findings suggest that there is activity-dependent plasticity in the serotonergic transcriptional network and that an activity-dependent homeostatic mechanism may transcriptionally adjust serotonergic neuromodulation.
Gata3. In Gata3-deficient mice, most precursors fail to initiate 5-HT synthesis in caudal rhombomeres. In contrast, 5-HT neuron differentiation is only modestly affected in the rostral hindbrain, suggesting a diminishing caudal-to-rostral gradient in Gata3 dependency 24, 28 . These findings suggest that Gata3 directly regulates Tph2 expression, although Gata3 binding sites in the Tph2 regulatory region have not been identified (Fig. 4) . Conditional targeting of Gata3 in 5-HT neurons has shown that ongoing Gata3 expression is also required to maintain normal levels of Tph2, Sert and, to a lesser extent, Aadc and Vmat2 (ref. 43 ).
Pet-1. Pet-1 is the only factor in the transcriptional network whose expression in the brain is restricted to 5-HT neurons 29, 30 . FEV (Fifth Ewing Variant), the human ortholog of Pet-1, is expressed specifically in the rhesus macaque 44 and human 45, 46 dorsal and median raphe. Similar to Gata3 and Lmx1b loss of function, constitutive loss of Pet-1 function does not alter the generation of 5-HT neurons precursors 47 . However, about 70% of these Pet-1 −/− cells fail to initiate 5-HT synthesis. The defect is roughly uniform across all raphe nuclei and leads to an 80% deficiency of 5-HT in the adult ascending and descending 5-HT subsystems 47 . These Pet-1 mutant precursors also fail to induce Tph2, Aadc, Sert, Vmat2 and Maob expression; thus, Pet-1 is required for induction of all of the genes in the serotonergic-type gene battery (Fig. 4) . It is not clear why Pet-1 is largely dispensable for serotonergic differentiation in 30% of 5-HT neuron precursors, although it was recently shown that the Pet-1-resistant 5-HT neurons constitute a phenotypically distinct ascending serotonergic subsystem that continues to innervate circuitry involved in neuroendocrine and autonomic control of stress responses 48 . Although other ETS transcripts were detected in dissected adult human raphe tissue 45 , whole genome expression profiling failed to identify enriched expression of other ETS genes in flow cytometry-sorted E12.5 mouse embryonic 5-HT neurons 49 , which, if detected, would have raised the simple explanation of paralog compensation in Pet-1-resistant 5-HT neurons.
Consistent with its ongoing expression in 5-HT neurons, conditional Pet-1 targeting with an ePet-Cre transgene 50 that is active at the postmitotic stage and results in the loss of Pet-1 1-2 d after serotonergic neurogenesis 43 showed that Pet-1 continues to function during the prolonged stage of 5-HT system maturation. First, although Pet-1-resistant 5-HT-positive neurons have normal axonal growth characteristics in culture 48 , conditionally targeted Pet-1-deficient neurons that lose the ability to synthesize 5-HT have altered axonal innervation patterns in the somatosensory cortex 43 . Although these results indicate a role in axonal development, it is not yet clear what specific role Pet-1 performs in regulating innervation patterns. The evolutionarily conserved role of different ETS factors in circuit formation suggests several possibilities: AST1-directed axon navigation in C. elegans 51 , mouse Pea3-directed axonal branching 52 or mouse ER81 control of target connectivity 53 . Second, in situ hybridization analyses and whole-cell electrophysiological recordings have shown that, during the maturation stage, Pet-1 is required to induce the 5-HT1a and 5-HT1b autoreceptor pathways 43, 54 , which are not expressed in the mouse brain until about E14. 5 (refs. 43,55) . The 5-HT1a autoreceptor pathway was not altered in conditionally targeted Gata3 mice, which places special importance on Pet-1 in this physiologically and clinically relevant regulatory event 56 . Conditional targeting of Pet-1 in adult 5-HT neurons with a tamoxifen-inducible ePet-CreER transgene revealed that Pet-1 is required for maintenance of Tph2 and Sert expression, but not for the expression of other genes whose induction depends on Pet-1 during serotonergic neurogenesis and maturation. Similarly, tamoxifen-induced targeting of Lmx1b in adult 5-HT neurons revealed that Lmx1b is also needed to maintain Tph2 and Sert expression, but not Pet-1 and Aadc expression 57 . In contrast with Pet-1, however, Lmx1b is also required to maintain Vmat2 expression, suggesting distinct regulatory roles for Pet-1 and Lmx1b in adulthood (Fig. 4) .
With the exception of Pet-1-DNA interactions, very little is known about the cis-regulatory modules by which factors in the network directly activate transcription of serotonergic genes. Conserved Pet-1 npg r e v i e w binding sites have so far been investigated in the upstream regions of the Sert, Tph2, Htr1a and Pet-1 genes 29, 43, 54 . In vitro DNA binding assays showed that bacterially expressed Pet-1 can bind conserved ETS-like sites present in the upstream regions of the Sert and Htr1a genes 29 . Further analysis revealed multiple conserved Pet-1 binding sites upstream of the human and rodent Htr1a genes 54 . Reporter assays in the HEK293 cell line showed that the activity of a 1.5-kb Hrt1a promoter construct was substantially reduced when the conserved GGAA core of any of the Pet-1 binding sites were destroyed. However, destruction of a single distal Pet-1 ETS site at −1,406 completely abolished promoter activity, suggesting that this site is critical for the regulation of Htr1a 54 . ChIP studies with chromatin isolated from embryonic hindbrain have shown that Pet-1 binds, in vivo, to the Tph2, Sert and Pet-1 upstream regulatory regions, where conserved Pet-1 binding sites are located 43 . In addition, Pet-1 enhancer activity is markedly reduced in 5-HT neurons lacking Pet-1 expression in adulthood; thus, ongoing Pet-1 binding is required to maintain its own expression. Together, these findings support a model (Fig. 4) in which induction of Pet-1 by the serotonergic transcription regulatory network is subsequently reinforced and stabilized through direct positive autoregulation to maintain Pet-1, Tph2 and Sert expression across the lifespan 43 .
In summary, the parallel transcriptional inputs of Gata3, Lmx1b and Pet-1 to the serotonergic-type gene battery constitute a combinatorial code that determines 5-HT neuron identity (Fig. 4) . Pet-1 functions as a terminal selector 38 , defined as an autoregulated gene that induces and maintains expression of cell type-specific gene battery across the lifespan through direct interaction with a common DNA regulatory motif. Pet-1, Lmx1b and Gata3 likely function together as combinatorial terminal selectors, although the latter two factors have not been shown to autoregulate or to directly control serotonergic genes. The essential role of Lmx1b, but not Gata3 and Pet-1, in all 5-HT neurons suggests that Lmx1b forms a distinct combinatorial code with other transcriptional inputs in a subset of 5-HT neurons. In light of the requirement for Lmx1b and Pet-1 in the maintenance of adult 5-HT synthesis and reuptake, together with the activitydependent regulation of Lmx1b 42 , it will be interesting to determine whether environmental input such as stress or drug exposure alters Pet-1-and/or Lmx1b-dependent regulation of serotonergic function in the mammalian brain.
Network alterations and pathogenesis
As alluded to at the beginning of this review, evidence from decades of studies in humans, nonhuman primates and rodents strongly support an association of altered serotonergic function with behavioral and physiological pathogenesis 56, 58, 59 . It is now well understood that genetically engineered alterations in the levels of Sert, Tph2 or Htr1a expression are not compatible with normal emotional and stressrelated behaviors, at least in mice [60] [61] [62] . Many other physiological processes are also disrupted in mice that are deficient for these genes, including growth trajectories, respiration, body weight maintenance, stress susceptibility, cardiovascular function, sleep patterns and maternal behavior 60, 63 . These genetic-based animal studies provide a compelling impetus for the quest to find gene variation that affects serotonergic signaling and risk for neuropsychiatric disease.
Numerous variants thought to affect presynaptic serotonergic signaling through intrinsic alterations in brain 5-HT neuron function have been discovered and investigated for association with neuropsychiatric disease or their influence on the function of neural circuitry shaping emotional responses 56, 59, 60, 64 . Most of these disease-associated 5-HT neuron variants have been examined to determine whether they have a functional effect in cultured cell lines, but not in brain 5-HT neurons. However, an intriguing commonality among the variants with a functional effect in vitro, and in some cases in vivo, is that they all affect the level of expression or activity of TPH2, SERT or HTR1A. Widely studied common polymorphisms in the human SERT transcriptional regulatory region affects the level of SERT transcription in cell culture 65, 66 and appears to moderate the effect of stressful life events on risk for adult depression 67 . An orthologous polymorphic region in rhesus macaques similarly influences stress reactivity in subjects exposed to adverse early rearing experiences 68 . Perhaps the most convincing example of disease-associated variation in SERT are the multiple, rare, nonsynonymous variants creating gain-of-function alleles that produce elevated levels of the transporter or enhanced trafficking-independent, 5-HT transport activity. Furthermore, these alleles encode transporters that are no longer sensitive to intracellular signaling pathways that control SERT trafficking and activity 69 . Notably, in a large sample of multiplex autism families, it was shown that these variants in aggregate are significantly associated with autism and rigid compulsive behaviors 70 . Despite its apparent very rare frequency 71 , another notable example of variation that affects the level of serotonergic activity is a nonsynonymous TPH2 single nucleotide coding variant, G1463A (ref. 72) . The encoded R441H TPH2 variant exhibits an 80% loss of 5-HT biosynthetic capacity in cell culture and has been associated with late-life depression 72 . An orthologous mouse knock-in allele causes severely reduced brain 5-HT synthesis, increased aggression and anxiety-like behaviors 61 . This allele recapitulated in the mouse many of the alterations in the levels of serotonergic biomarker indices that are associated with depression in humans 73 , reinforcing the idea that the altered human indices do indeed reflect reduced brain 5-HT levels and neuropsychiatric disease.
In light of the human genetic evidence and abundant animal studies that support altered levels of 5-HT signaling in disease susceptibility, a natural, but largely unexplored, question is whether variation in the serotonergic transcription regulatory network (Fig. 4) affects the level of 5-HT neuron gene expression and susceptibility to mental illness. So far, variation with such an effect has not been discovered. However, several findings in nonhuman primates and mice highlight network variation as a potentially important mechanism in neuropsychiatric disease pathogenesis. First, studies of female cynomolgus monkeys have defined a stress-sensitive subgroup, in which reproductive function is impaired, versus highly stress resilient (HSR) individuals who showed no reproductive suppression 44 . Interestingly, in stress-sensitive individuals, the level of FEV expression in the dorsal raphe is significantly reduced compared with FEV expression in the HSR dorsal raphe 44 . Moreover, the levels of expression of TPH2, SERT and the HTR1A autoreceptor genes were correspondingly decreased in stress-sensitive DRN compared with the HSR DRN, suggesting that FEV-dependent transcriptional regulation of 5-HT synthesis, reuptake and autosensing was potentially altered in response to stress in female macaques 44, 74 . Second, Lmx1b-and Pet-1-deficient mice show several emotion-and stress-related behavioral abnormalities that parallel those observed in Tph2, Sert and Htr1a targeted mice, including increase aggression, anxiety-like behavior and fear responses 47, 48, 75 . Notably, Pet-1-dependent transcription is required into adulthood to maintain normal anxietylike behaviors 43 , raising the possibility that behavioral pathogenesis might arise from adult onset disruption, genetically or environmentally, of serotonergic transcription. In addition, neonatal growth, respiration, thermoregulation, autonomic control of neonatal cardiac function, nociception and circadian rhythms are disrupted in Lmx1b −/− and Pet-1 −/− mice [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] , suggesting that network alterations have widespread effects. Third, transgenic experiments have shown that the extent of r e v i e w transgenic rescue of 5-HT neuron molecular defects and maternal behavior deficits in Pet-1 −/− mice is dependent on the level of expression of a FEV BAC transgene 86 . These later findings provide evidence in support of the idea that the expression level of serotonergic regulatory network determines the levels of 5-HT neuron gene expression with attendant quantitative effects on 5-HT-modulated behaviors.
Given the direct regulation of the Tph2, Sert and Htr1a genes by Pet-1 and, probably, by Lmx1b, naturally occurring human alleles of these two network components are particularly intriguing as a source of potential disease-relevant variation. The restricted expression of FEV in the brain suggests that different functional FEV alleles, if they exist, may have 5-HT system-specific effects. Positive or negative epistasis 87 with other network alleles may determine whether or not FEV alleles have deleterious effects on 5-HT system activity. However, naturally occurring functional variation in the serotonergic regulatory network would be expected, in most instances, to exact variable pleiotropic effects, as all of the others factors in the network are broadly expressed in multiple unrelated lineages in the brain and peripheral tissues. Human genetic studies of LMX1B variation provide an instructive example. Over 100 distinct heterozygous autosomal dominant LMX1B missense, nonsense and deletion mutations have been identified in different cases of nail patella syndrome (NPS), a disorder of highly variable expressivity and penetrance that can include nail dysplasia, skeletal malformations, renal defects, sensory deficits and ocular malformations 39, 88, 89 . In support of LMX1B loss of function in NPS, Lmx1b-deficient mice display several defining features of the syndrome 90 . Many of the human mutations encode homeodomain missense and disrupt sequence-specific DNA binding, suggesting direct effects on network interactions and downstream transcriptional targets. The likely haploinsufficiency of LMX1B in NPS 91 suggests that LMX1B-dependent transcriptional networks are particularly sensitive to the level of LMX1B activity. Given its function in the serotonergic regulatory network, we imagine that network activity is altered in at least some NPS individuals.
Although not yet studied in sufficient depth to establish a clear link to neuropsychiatric disease, disrupted LMX1B binding may promote susceptibility to ADHD and major depressive disorder in NPS cases 92 . Further study of this possibility, including quantitative analysis of disease-associated serotonergic biomarker indices in NPS individuals, is of interest in the search for the genetic basis of serotonergic dysfunction in neuropsychiatric disorders.
Conclusions and future directions
A detailed understanding of the spatiotemporal expression patterns and functions of eight transcription factors has enabled the construction of a model for the dynamic regulatory network that specifies brain 5-HT neurons (Fig. 4) . The network comprises temporally distinct regulatory states with each corresponding to a particular stage in the development of 5-HT neuron identity and its maintenance in adulthood. Despite the well-studied effects of specific network perturbations on 5-HT neuron identity, as well as a growing understanding of its effects on behavior and physiology, several critical gaps remain. For example, despite numerous obvious signs of network heterogeneity, our understanding of it is insufficient to explain why the phenotype of substantial numbers of 5-HT neurons are resistant to the loss of individual transcription factors and how diverse axonal trajectories, cell body migratory routes and physiological properties of different groups of 5-HT neurons are programmed. In addition, nothing is known about the layer of epigenetic transcriptional control in the network and how it responds to environmental signals that may help to shape 5-HT-modulated behaviors. Further study of the network with new genetic-based approaches that provide greater access to 5-HT neurons 50, 93 should help fill in these gaps and provide a better understanding of how it controls 5-HT function.
An additional theme of this review is the potential utility of our network model in helping to advance an understanding of the importance of 5-HT system dysfunction in neuropsychiatric disease pathogenesis. Given the likely essential role of the orthologous human network in the induction of the disease-associated genes TPH2, SERT and HTR1A, genetically or epigenetically driven alterations in expression or function of the network may program altered levels of 5-HT synthesis, reuptake or autoreceptor function and establish a vulnerability for mental illness. The identification of multiple biologically relevant rare disease-associated variants in SERT, TPH2 and LMX1B is consistent with the now widely recognized fact that substantial heterogeneity exists in the allelic architecture of complex human disorders in general and particularly for neuropsychiatric disorders [94] [95] [96] . As an experimentally well-defined cell type-specific biological pathway, the serotonergic regulatory network is a potentially rich source of rare or common heritable or de novo human variation that, if discovered, can be investigated for functional effect in the context of brain 5-HT system development and neuromodulation. The utility of our model is its power to help interpret the biological importance of network variants in an ensemble of functionally interacting serotonergic transcriptional determinants. Orthologous mutations can be investigated to study their effect on serotonergic differentiation of cultured embryonic stem cells 97, 98 and introduced into the mouse genome to determine their effect on 5-HT modulated behaviors and physiology. Functionally defined network variants can then be investigated to determine whether they are present in unrelated individuals with particular neuropsychiatric diagnoses 99 , as has been accomplished for LMX1B variants in NPS and with SERT variants in autism.
